Navigation Links
Amylin Pharmaceuticals Highlights 2009 Value Creation Opportunities
Date:1/12/2009

anner; our obesity development and funding strategy not being finalized in a timely manner; our expense reductions may not be as large as we expect; or manufacturing and supply issues. The potential for BYETTA and SYMLIN may also be affected by government and commercial reimbursement and pricing decisions, the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the development and commercialization of pharmaceutical products. These and additional risks and uncertainties are described more fully in Amylin's most recent SEC filings including its Quarterly Report on Form 10-Q. Amylin undertakes no duty to update these forward-looking statements.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... AVIV, Israel , July 23, 2014 /PRNewswire/ ... ., a portfolio company of Trendlines Agtech ... one of Israel,s leading ... http://photos.prnewswire.com/prnh/20140121/666259-a) , Valentis,s technology combines nanocrystalline ... plant pulp waste, with additional nanoparticles to produce ...
(Date:7/23/2014)... , July 23, 2014 regulated information ... research and development pipeline with positive topline results ... brivaracetam . This study was designed to evaluate the ... and 200 mg/day, without titration) compared to placebo, ... with partial-onset seizures, not fully controlled despite treatment ...
(Date:7/23/2014)... PARK, Calif. , July 23, 2014  Sofinnova ... investment firm, today announced the closing of Sofinnova Venture ... million and in excess of the initial fund target ... helping entrepreneurs build successful biotechnology companies. Consistent with recent ... with promising later stage clinical programs, along with select ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
... Radi Medical Systems Sponsors Case Review with Drs. Morton Kern, Nico ... ... Oct. 19 The use,of fractional flow reserve (FFR) for optimizing ... Cardiovascular,Therapeutics symposium, TCT 2007, which will take place Oct. 20-25 in,Washington. ...
... /Xinhua-PRNewswire-FirstCall/ -- Simcere,Pharmaceutical Group (NYSE: SCR ), ... in the rapidly growing Chinese marketplace,announced today that ... results,on Monday, November 5, 2007, before the market ... Jinsheng Ren, and chief financial,officer, Frank Zhigang Zhao, ...
... BSX ) today announced financial results for the third,quarter ended ... per share (EPS) for the fourth quarter of 2007. Highlights ... at the mid-point of guidance, and adjusted ... one position in the worldwide drug-eluting stent (DES) ...
Cached Biology Technology:Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 2Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 4Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 5Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 6Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 7Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 8Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 9Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 10Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 11Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 12Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 13Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 14Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 15Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 16Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 17Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 18Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 19Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 20Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 21Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 22Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 23Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 24Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 25
(Date:7/23/2014)... WOODS HOLE, MA -- What do mollusks, starfish, ... shared marine habitat, they are all calcifiersorganisms that ... carbonate skeletons and shells for stability and protection. ... Bulletin , published by the Marine Biological Laboratory, ... ocean composition changes worldwide. , As atmospheric carbon ...
(Date:7/23/2014)... 2014   MedNet Solutions , a global ... management systems, is pleased to announce that ... industry executive with over 25 years of experience, ... will be responsible for MedNet,s day-to-day operating activities, ... quality product/service delivery.  "We welcome ...
(Date:7/23/2014)... . , Animals ... which might be very different from ours. Some bird ... sunlight in the atmosphere to calibrate their orientation systems. ... in Seewiesen, Germany, and Queen,s University Belfast have discovered ... the greater mouse-eared bat, has the capability to orient ...
Breaking Biology News(10 mins):Calcification in changing oceans explored in special issue of The Biological Bulletin 2MedNet Appoints Clareece West As Chief Operating Officer 2Bats use the evening sky's polarization pattern for orientation 2
... NEW YORK (Feb. 29, 2008) -- Teens who can ... ads are less likely to succumb to alcohol advertising ... a three-year study of inner-city middle school students by ... journal Addictive Behaviors (April print edition). Previous research has ...
... derives from the red jungle fowl, but new research from ... chicken are more complicated than that. The ... legs and found to their surprise that this genetic heredity ... The study is being published today in the Web ...
... discovered how roots find their way past obstacles to grow ... Science, also explains how germinating seedlings penetrate the soil without ... in the fuzzy coat of hairs on the roots of ... control mechanism that enables these hairs to find their way ...
Cached Biology News:Learning how to say 'no' to alcohol advertising and peer pressure works for inner-city adolescents 2Darwin was wrong about the wild origin of the chicken 2